Anti-idiotypic antibody neutralizing the inhibitor activity of a factor VIII inhibitor antibody
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Dec 6, 2011
Grant Date -
Mar 22, 2007
app pub date -
Jul 18, 2006
filing date -
Aug 4, 2005
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The present invention is related to a monoclonal anti-idiotypic antibody directed against a Factor VIII inhibitor antibody binding to the domain A2 of Factor VIII, and to a cell line producing this monoclonal anti-idiotypic antibody, to the use of this monoclonal anti-idiotypic antibody as drug, and more particularly, to its use for the manufacturing of a drug to be used for the treatment of haemophilia A.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully